Kiniksa Pharmaceuticals News - KNSA

Company Name	Stock Ticker Symbol	Market	Type
Kiniksa Pharmaceuticals Ltd	KNSA	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.16	-0.90%	17.52	18:02:03

Open Price	Low Price	High Price	Close Price	Prev Close
18.21	17.64	18.61	17.86	17.68

more quote information »

Recent News

Date	Time	Source	Heading
4/23/2024	07:30	GLOBE	Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial..
4/16/2024	16:01	GLOBE	Kiniksa Pharmaceuticals to Report First Quarter 2024..
4/02/2024	07:30	GLOBE	Kiniksa Pharmaceuticals Announces Development Indication for..
3/05/2024	16:34	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/05/2024	16:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/01/2024	17:29	EDGAR2	Form 144 - Report of proposed sale of securities
2/29/2024	16:26	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/28/2024	07:35	EDGAR2	Form 8-K - Current report
2/28/2024	07:30	GLOBE	Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year..
2/27/2024	17:06	EDGAR2	Form 144 - Report of proposed sale of securities
2/21/2024	16:01	GLOBE	Kiniksa Pharmaceuticals to Report Fourth Quarter and..
2/14/2024	16:39	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/14/2024	15:46	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/04/2024	16:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/04/2024	07:37	EDGAR2	Form 8-K - Current report
1/04/2024	07:30	GLOBE	Kiniksa Pharmaceuticals Provides Corporate Update
1/03/2024	16:55	EDGAR2	Form 144 - Report of proposed sale of securities
1/02/2024	16:01	GLOBE	Kiniksa Pharmaceuticals to Present at 42nd Annual J.P...
12/11/2023	16:20	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/07/2023	16:46	EDGAR2	Form 144 - Report of proposed sale of securities
11/02/2023	16:15	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/31/2023	07:35	EDGAR2	Form 8-K - Current report
10/31/2023	07:30	GLOBE	Kiniksa Pharmaceuticals Reports Third Quarter 2023 Financial..
10/24/2023	16:01	GLOBE	Kiniksa Pharmaceuticals to Report Third Quarter 2023..
9/06/2023	19:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/06/2023	19:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/06/2023	19:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/06/2023	19:03	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/05/2023	17:26	EDGAR2	Form 144 - Report of proposed sale of securities
8/18/2023	16:32	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
8/10/2023	16:15	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
8/01/2023	16:15	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/27/2023	16:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/25/2023	17:14	EDGAR2	Form 144 - Report of proposed sale of securities
7/25/2023	07:40	EDGAR2	Form 8-K - Current report
7/25/2023	07:30	GLOBE	Kiniksa Pharmaceuticals Reports Second Quarter 2023..
7/17/2023	08:00	GLOBE	Kiniksa Pharmaceuticals to Report Second Quarter 2023..
6/06/2023	16:01	GLOBE	Kiniksa Pharmaceuticals to Present at Goldman Sachs 44th..
5/02/2023	07:30	GLOBE	Kiniksa Pharmaceuticals Reports First Quarter 2023 Financial..
5/01/2023	16:01	GLOBE	Kiniksa Pharmaceuticals to Report First Quarter 2023..